Audience Targeting Endpoints News operates at the intersection of science money and power in biopharma, suggesting a strong audience of biotech executives, researchers, investors and industry analysts. Leverage content sponsorships, targeted newsletters, and executive briefings to reach decision-makers involved in funding, partnerships and regulatory strategy.

Content Partnerships Recent collaboration activity including webinars with Novotech and coverage hires indicates openness to co-branded educational events and sponsored content. Propose joint webinars, expert Q&A sessions, and sponsored rapid analysis pieces to enhance visibility among pharma and biopharma communities.

Platform & Tech The tech stack includes RSS, MySQL, JSON-LD, PWA and analytics tools, suggesting capabilities for personalized content delivery and measurable engagement. Offer integrations for sponsored content, retargeting campaigns and data-driven outreach based on audience segments and article engagement.

Market Position As a FT Specialist-backed leading source for biopharma news, Endpoints holds credibility with industry insiders. Position premium market intel, exclusive analysis, and startup coverage as differentiators in sponsorships and branded thought leadership campaigns.

Growth Signals Revenue range and recent hiring of health technology and FDA reporters signal expanding coverage and audience demand. Target offerings around premium reports, event sponsorships, and tailored briefs for growth-stage biotech companies, CROs, and funding groups seeking exposure and lead generation.